Evidence for the participation of the nitric oxide–cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test
- 21 April 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 395 (1) , 9-13
- https://doi.org/10.1016/s0014-2999(00)00157-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Characterization of prostanoid receptor‐evoked responses in rat sensory neuronesBritish Journal of Pharmacology, 1998
- The Interaction of FK409, a Novel Nitric Oxide Releaser, and Peripherally Administered Morphine During Experimental InflammationAnesthesia & Analgesia, 1998
- Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitorBrain Research, 1996
- Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolacEuropean Journal of Pharmacology, 1996
- Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolacEuropean Journal of Pharmacology, 1995
- Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in ratsPain, 1993
- Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the ratNeuropharmacology, 1992
- The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide releaseEuropean Journal of Pharmacology, 1991
- Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathwayEuropean Journal of Pharmacology, 1990
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983